Data / Drug companies / Aaa Pharmaceutical, Inc.
Aaa Pharmaceutical, Inc.: 28 products in the FDA NDC directory, labeler code 57344
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Aaa Pharmaceutical, Inc. (labeler code 57344) lists 28 products in the FDA National Drug Code Directory, covering 13 finished drugs by generic name. By type: 28 over the counter drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on April 30, 2026.
The request: Watch Aaa Pharmaceutical, Inc. (FDA labeler code 57344): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 57344
- Products in commercial distribution
- 28
- Packages
- 51
- Finished drugs by generic name
- 13
- Prescription products
- 0
- Over the counter products
- 28
- Flagged as original packager
- 23 of 23 products that carry the flag
- Started marketing in the last 12 months
- 2
- Earliest marketing start
- April 1, 2012
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 14 | 50% |
| Over the counter monograph drugs | 14 | 50% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 28 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Acetaminophen | 6 | 214 |
| Ibuprofen | 5 | 190 |
| Aspirin | 3 | 134 |
| Naproxen sodium | 2 | 100 |
| Diphenhydramine hydrochloride | 2 | 127 |
| Cetirizine hydrochloride | 1 | 119 |
| Acetaminophen and diphenhydramine hydrochloride | 1 | 29 |
| Guaifenesin | 1 | 123 |
| Loratadine | 1 | 125 |
| Acetaminophen, aspirin and caffeine | 1 | 26 |
| Fexofenadine hydrochloride | 1 | 65 |
| Acetaminophen and phenylephrine hydrochloride | 1 | 13 |
| Caffeine | 1 | 38 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, coated | 17 | 60.7% |
| Tablet | 6 | 21.4% |
| Tablet, extended release | 3 | 10.7% |
| Tablet, delayed release | 2 | 7.1% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Naproxen Sodium | 57344-244 | Tablet, coated | Generic drugs (ANDA) | April 30, 2026 |
| Ibuprofen | 57344-212 | Tablet, coated | Generic drugs (ANDA) | February 16, 2026 |
| Arthritis Pain | 57344-200 | Tablet, extended release | Generic drugs (ANDA) | September 12, 2025 |
| Pain Relief | 57344-103 | Tablet | Over the counter monograph drugs | June 2, 2025 |
| Ibuprofen | 57344-309 | Tablet, coated | Generic drugs (ANDA) | December 5, 2024 |
| 8HR Muscle Aches and Pain | 57344-201 | Tablet, extended release | Generic drugs (ANDA) | April 15, 2024 |
| Stay Awake | 57344-220 | Tablet | Over the counter monograph drugs | April 1, 2024 |
| Mucus Relief | 57344-203 | Tablet, extended release | Generic drugs (ANDA) | February 1, 2024 |
| Migraine Relief | 57344-205 | Tablet | Generic drugs (ANDA) | May 3, 2023 |
| Allergy Relief | 57344-292 | Tablet | Generic drugs (ANDA) | July 6, 2021 |
| Allergy Relief | 57344-193 | Tablet | Generic drugs (ANDA) | August 14, 2020 |
| Allergy Multi Symptom | 57344-928 | Tablet, coated | Over the counter monograph drugs | August 1, 2020 |
| Sinus and Headache | 57344-923 | Tablet, coated | Over the counter monograph drugs | August 1, 2020 |
| Ibuprofen | 57344-811 | Tablet, coated | Generic drugs (ANDA) | February 1, 2020 |
| Diphenhydramine Hydrochloride | 57344-091 | Tablet, coated | Over the counter monograph drugs | October 5, 2018 |
| Allergy Relief | 57344-194 | Tablet, coated | Generic drugs (ANDA) | October 1, 2018 |
| Aspirin | 57344-146 | Tablet, delayed release | Over the counter monograph drugs | September 1, 2017 |
| Aspirin | 57344-018 | Tablet, coated | Over the counter monograph drugs | September 1, 2017 |
| Aspirin | 57344-080 | Tablet, delayed release | Over the counter monograph drugs | July 1, 2017 |
| Pain Relief | 57344-170 | Tablet, coated | Over the counter monograph drugs | January 1, 2015 |
| Ibuprofen | 57344-110 | Tablet, coated | Generic drugs (ANDA) | September 1, 2014 |
| Pain Relief | 57344-301 | Tablet | Over the counter monograph drugs | December 13, 2012 |
| Ibuprofen | 57344-109 | Tablet, coated | Generic drugs (ANDA) | October 1, 2012 |
| Acetaminophen PM | 57344-095 | Tablet, coated | Over the counter monograph drugs | October 1, 2012 |
| Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride | 57344-163 | Tablet, coated | Over the counter monograph drugs | August 2, 2012 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.